FDA Inspection 1264401 — CHI Health CUMC - Bergan Mercy

CHI Health CUMC - Bergan Mercy — FEI 3008819868

The FDA completed an inspection of CHI Health CUMC - Bergan Mercy on March 18, 2025 in Omaha, NE. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 18, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Omaha, NE (United States)